ABBV vs ADBE: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Adobe Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Adobe Inc. · Technology
$238.25
+13.5% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
ADBE has more upside to fair value
(+13.5%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ADBE |
| Current Price |
$261.70 |
$238.25 |
| Fair Value Estimate |
$259.04 |
$270.38 |
| Upside to Fair Value |
-1.0%
|
+13.5%
|
| Market Cap |
$462.4B |
$94.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
9.5x
|
| Price / Sales |
7.2x
|
3.6x
|
| Price / FCF |
23.6x
|
8.6x
|
| Revenue Growth YoY |
+10.2%
|
+12.9%
|
| Gross Margin |
71.5%
|
89.1%
|
| Operating Margin |
29.3%
|
35.7%
|
| Return on Equity |
-136.5%
|
62.9%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
11.63%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 pe…
Accumulation Zones
| Metric |
ABBV |
ADBE |
| Zone Low |
$194.28 |
$202.78 |
| Zone High |
$220.18 |
$229.82 |
| In Buy Zone? |
No
|
No
|